Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: A matched case-control study

American Journal of Infection Control

Volumn 42, Issue 9, 2014, Pages 1006-1008

  Gagliotti, Carlo ^a   Giordani, Stefano ^b   Ciccarese, Vincenzo ^b   Barozzi, Agostino ^b   Giovinazzi, Antonio ^c   Pietrantonio, Anne Marie ^b   Moro, Maria Luisa ^a   Pinelli, Giovanni ^b   Sarti, Mario ^b  

^a Agency for Health and Social Care of Emilia Romagna   (Italy)

^b Nuovo Ospedale S Agostino   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antibiotic prescription; Carbapenemase; Carrier; Klebsiella pneumoniae

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

AGED; CASE CONTROL STUDY; CROSS INFECTION; ENZYMOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; HUMAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; METABOLISM; MICROBIOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84906840974     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.05.028     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available from: http://www.cdc.gov/drugresistance/ threat-report-2013/. Accessed May 5, 2014.
2. L.S. Munoz-Price, L. Poirel, R.A. Bonomo, M.J. Schwaber, G.L. Daikos, and M., Cormican et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases Lancet Infect Dis 13 2013 785 796
3. C. Gagliotti, V. Ciccarese, M. Sarti, S. Giordani, A. Barozzi, and C. Braglia et al. Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting J Hosp Infect 83 2013 330 332
4. L. Rodrigues, and B.R. Kirkwood Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls Int J Epidemiol 19 1990 205 213
5. M.E. Charlson, F.L. Sax, C.R. MacKenzie, S.D. Fields, R.L. Braham, and R.G. Douglas Jr. Assessing illness severity: does clinical judgment work? J Chronic Dis 39 1986 439 452
6. S. Katz Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living J Am Geriatr Soc 31 1983 721 727
7. W.R. McCabe, and G.G. Jackson Gram-negative bacteremia: etiology and ecology Arch Intern Med 110 1962 847 855
8. W.D. Dupont Power calculations for matched case-control studies Biometrics 44 1988 1157 1168
9. M.J. Schwaber, B. Lev, A. Israeli, E. Solter, G. Smollan, and B. Rubinovitch et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention Clin Infect Dis 52 2011 848 855
10. M. Swaminathan, S. Sharma, B.S. Poliansky, G. Patel, D.B. Banach, and M. Phillips et al. Prevalence and risk factors for acquisition of carbapenem-resistant enterobacteriaceae in the setting of endemicity Infect Control Hosp Epidemiol 34 2013 809 817
11. M.E. Falagas, P.I. Rafailidis, D. Kofteridis, S. Virtzili, F.C. Chelvatzoglou, and V. Papaioannou et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study J Antimicrob Chemother 60 2007 1124 1130
12. K. Hussein, H. Sprecher, T. Mashiach, I. Oren, I. Kassis, and R. Finkelstein Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns Infect Control Hosp Epidemiol 30 2009 666 671
13. D. Marchaim, T. Chopra, A. Bhargava, C. Bogan, S. Dhar, and K. Hayakawa et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship Infect Control Hosp Epidemiol 33 2012 817 830
14. G. Patel, S. Huprikar, S.H. Factor, S.G. Jenkins, and D.P. Calfee Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies Infect Control Hosp Epidemiol 29 2008 1099 1106
15. N. Patel, S. Harrington, A. Dihmess, B. Woo, R. Masoud, and P. Martis et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae J Antimicrob Chemother 66 2011 1600 1608
16. M.J. Schwaber, S. Klarfeld-Lidji, S. Navon-Venezia, D. Schwartz, A. Leavitt, and Y. Carmeli Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality Antimicrob Agents Chemother 52 2008 1028 1033
17. L.B. Gasink, P.H. Edelstein, E. Lautenbach, M. Synnestvedt, and N.O. Fishman Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae Infect Control Hosp Epidemiol 30 2009 1180 1185
18. D. Ben David, S. Masarwa, S. Navon-Venezia, H. Mishali, I. Fridental, and B. Rubinovitch et al. Carbapenem-resistant Klebsiella pneumoniae in post-acute care facilities in Israel Infect Control Hosp Epidemiol 32 2011 845 853